BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Droguerre M, Tsurugizawa T, Duchêne A, Portal B, Guiard BP, Déglon N, Rouach N, Hamon M, Mouthon F, Ciobanu L, Charvériat M. A New Tool for In Vivo Study of Astrocyte Connexin 43 in Brain. Sci Rep 2019;9:18292. [PMID: 31797899 DOI: 10.1038/s41598-019-54858-9] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 3.7] [Reference Citation Analysis]
Number Citing Articles
1 Dong R, Lv P, Han Y, Jiang L, Wang Z, Peng L, Ma Z, Xia T, Zhang B, Gu X. Enhancement of astrocytic gap junctions Connexin43 coupling can improve long‐term isoflurane anesthesia–mediated brain network abnormalities and cognitive impairment. CNS Neurosci Ther. [DOI: 10.1111/cns.13974] [Reference Citation Analysis]
2 Bigarreau J, Rouach N, Perrier AL, Mouthon F, Charvériat M. Modeling and Targeting Neuroglial Interactions with Human Pluripotent Stem Cell Models. Int J Mol Sci 2022;23:1684. [PMID: 35163606 DOI: 10.3390/ijms23031684] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
3 Kumamoto T, Tsurugizawa T. Potential of Multiscale Astrocyte Imaging for Revealing Mechanisms Underlying Neurodevelopmental Disorders. Int J Mol Sci 2021;22:10312. [PMID: 34638653 DOI: 10.3390/ijms221910312] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
4 Morioka N, Kondo S, Takimoto T, Tokunaga N, Nakamura Y, Hisaoka-Nakashima K. Decreased connexin43 expression in the hippocampus is related to the antidepressant effect of amitriptyline in neuropathic pain mice. Biochem Biophys Res Commun 2021;566:141-7. [PMID: 34126344 DOI: 10.1016/j.bbrc.2021.06.020] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
5 Stephan J, Eitelmann S, Zhou M. Approaches to Study Gap Junctional Coupling. Front Cell Neurosci 2021;15:640406. [PMID: 33776652 DOI: 10.3389/fncel.2021.640406] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 11.0] [Reference Citation Analysis]
6 Charvériat M, Mouthon F, Rein W, Verkhratsky A. Connexins as therapeutic targets in neurological and neuropsychiatric disorders. Biochim Biophys Acta Mol Basis Dis 2021;1867:166098. [PMID: 33545299 DOI: 10.1016/j.bbadis.2021.166098] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 6.0] [Reference Citation Analysis]
7 Charvériat M, Guiard BP. Serotonergic neurons in the treatment of mood disorders: The dialogue with astrocytes. Prog Brain Res 2021;259:197-228. [PMID: 33541677 DOI: 10.1016/bs.pbr.2021.01.006] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
8 Soleilhac E, Comte M, da Costa A, Barette C, Picoli C, Mortier M, Aubry L, Mouthon F, Fauvarque MO, Charvériat M. Quantitative Automated Assays in Living Cells to Screen for Inhibitors of Hemichannel Function. SLAS Discov 2021;26:420-7. [PMID: 32914684 DOI: 10.1177/2472555220954388] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
9 Vidal B, Droguerre M, Valdebenito M, Zimmer L, Hamon M, Mouthon F, Charvériat M. Pharmaco-fUS for Characterizing Drugs for Alzheimer's Disease - The Case of THN201, a Drug Combination of Donepezil Plus Mefloquine. Front Neurosci 2020;14:835. [PMID: 32903470 DOI: 10.3389/fnins.2020.00835] [Cited by in Crossref: 10] [Cited by in F6Publishing: 12] [Article Influence: 5.0] [Reference Citation Analysis]
10 Droguerre M, Duchêne A, Picoli C, Portal B, Lejards C, Guiard BP, Meunier J, Villard V, Déglon N, Hamon M, Mouthon F, Charvériat M. Efficacy of THN201, a Combination of Donepezil and Mefloquine, to Reverse Neurocognitive Deficits in Alzheimer's Disease. Front Neurosci 2020;14:563. [PMID: 32612499 DOI: 10.3389/fnins.2020.00563] [Cited by in Crossref: 10] [Cited by in F6Publishing: 12] [Article Influence: 5.0] [Reference Citation Analysis]